Sana Biotechnology (SANA) Operating Expenses (2020 - 2026)
Sana Biotechnology (SANA) posted Operating Expenses of $48.6 million for Q1 2026, up 1651.22% sequentially from $2.8 million in Q4 2025, and down 3.98% YoY from $50.6 million in Q1 2025.
Sana Biotechnology (SANA) Operating Expenses (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Operating Expenses for 7 years, with the latest figure at $48.6 million in Q1 2026.
- Quarterly Operating Expenses fell 3.98% year-over-year to $48.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.7 million (down 9.48% YoY) and the FY2025 annual result came in at $9.3 million, down 37.72% from the prior year.
- Operating Expenses rose to $48.6 million in Q1 2026 per SANA's latest filing, from $2.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $116.3 million in Q2 2023 and troughed at -$182.2 million in Q4 2023.
- A 5-year average of $10.0 million and a median of $4.1 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses tumbled 245.76% in 2022, then jumped 1147.35% in 2025.
- Over 5 years, Operating Expenses stood at -$162.2 million in 2022, then fell by 12.33% to -$182.2 million in 2023, then soared by 101.43% to $2.6 million in 2024, then climbed by 6.56% to $2.8 million in 2025, then soared by 1651.22% to $48.6 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $48.6 million, $2.8 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - | 65.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.42 Mn |
| Mar 31, 2026 | 48.61 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 50.63 Mn |
| Dec 31, 2024 | 2.61 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Jun 30, 2024 | 5.29 Mn |
| Mar 31, 2024 | 4.06 Mn |
| Dec 31, 2023 | -182.21 Mn |
| Sep 30, 2023 | 2.18 Mn |
| Jun 30, 2023 | 116.29 Mn |
| Mar 31, 2023 | 84.05 Mn |
| Dec 31, 2022 | -162.20 Mn |
| Sep 30, 2022 | 86.19 Mn |
| Jun 30, 2022 | 72.90 Mn |
| Mar 31, 2022 | 31.69 Mn |
| Dec 31, 2021 | 111.28 Mn |
| Sep 30, 2021 | 83.43 Mn |